On 6/20/24, Harrow Health Inc (NASDAQ: HROW) stock enjoyed a major increase of 12.9%, closing at $19.93. Moreover, exceptionally high trading volume at 245% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 10.2% during the last week.
Current PriceTarget Research Rating
HROW is expected to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Harrow Health has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Harrow Health has a poor Appreciation Score of 23 but a slightly positive Power Rating of 68, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment